Results 41 to 50 of about 2,885,121 (322)

Can Cut-Off-Values for Tumor Size or Patient Age in Breast Ultrasound Reduce Unnecessary Biopsies or is it all About Bi-rads?– A Retrospective Analysis of 763 Biopsied T1-Sized Lesions

open access: yesUltrasound International Open, 2017
Aims and Objectives To assess whether it is possible to establish a size cut-off-value for sonographically visible breast lesions in a screening situation, under which it is justifiable to obviate a biopsy and to evaluate the grayscale characteristics of
Laura Holzer-Fruehwald   +5 more
doaj   +1 more source

The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic Review

open access: yesFrontiers in Oncology, 2020
Breast cancer is the most common malignancy diagnosed during pregnancy. Strong data on the genomic profile of pregnancy-associated breast cancer are lacking.
Anna-Maria Korakiti   +4 more
doaj   +1 more source

High-resolution synthesis of high-density breast mammograms: Application to improved fairness in deep learning based mass detection [PDF]

open access: yes, 2022
Computer-aided detection systems based on deep learning have shown good performance in breast cancer detection. However, high-density breasts show poorer detection performance since dense tissues can mask or even simulate masses. Therefore, the sensitivity of mammography for breast cancer detection can be reduced by more than 20% in dense breasts ...
arxiv   +1 more source

Supervised risk predictor of breast cancer based on intrinsic subtypes.

open access: yesJournal of Clinical Oncology, 2009
UNLABELLED PURPOSE To improve on current standards for breast cancer prognosis and prediction of chemotherapy benefit by developing a risk model that incorporates the gene expression-based "intrinsic" subtypes luminal A, luminal B, HER2-enriched, and ...
J. Parker   +19 more
semanticscholar   +1 more source

A gene-expression signature as a predictor of survival in breast cancer.

open access: yesNew England Journal of Medicine, 2002
BACKGROUND A more accurate means of prognostication in breast cancer will improve the selection of patients for adjuvant systemic therapy. METHODS Using microarray analysis to evaluate our previously established 70-gene prognosis profile, we classified
M. J. van de Vijver   +20 more
semanticscholar   +1 more source

A Comparative Study of the Diagnostic Performance of Evaluating Breast Masses for Breast Surgeons versus S-DetectTM(Samsung Medison Co., Ltd, Seoul, Korea)

open access: yesJournal of Surgical Ultrasound, 2019
Purpose: Ultrasonography is widely used for examining breast mass. We used the Breast Imaging-Reporting and Data System (BI-RADS) to characterize breast lesions found on ultrasonography.
Haram Kim   +5 more
doaj   +1 more source

Mammographic compression practices of force‐ and pressure‐standardisation protocol: A scoping review

open access: yesJournal of Medical Radiation Sciences, 2020
Introduction As an efficient, effective and moderately inexpensive modality, mammography has been implemented as a cancer screening tool and in diagnostic management. However, appropriate breast compression is necessary for optimal outcomes.
Elizabeth Serwan   +3 more
doaj   +1 more source

Breast Cancer Detection Using Deep Learning Technique Based On Ultrasound Image [PDF]

open access: yesarXiv, 2023
Breast cancer ranks as the most prevalent form of cancer diagnosed in women, and diagnosis faces several challenges, a change in the size, shape and appearance of breasts, dense breast tissue, lumps or thickening in the breast especially if in only one breast, lumps and nodules in the breast.
arxiv  

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

open access: yesNew England Journal of Medicine, 2004
BACKGROUND The likelihood of distant recurrence in patients with breast cancer who have no involved lymph nodes and estrogen-receptor-positive tumors is poorly defined by clinical and histopathological measures. METHODS We tested whether the results of
S. Paik   +17 more
semanticscholar   +1 more source

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

open access: yesThe Journal of the National Comprehensive Cancer Network, 2021
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants associated with increased risk of breast, ovarian, and pancreatic cancer and ...
M. Daly   +33 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy